Replies to post #109507 on Biotech Values

[HattieTheWitch]

Bottom line - providing a 1 or 2 page summary of where you think characterization is necessary and why your proprietary techniques help (but no discussion of those trade secret techniques) seems quite reasonable. That said, it is clearly within their rights not to discuss it - but if they choose that route it should be expected that people like me will be a little more doubtful if Momenta claims 'we told them the route to take'.

(italics above are mine)

If we (MNTA) told who the route to take?

Maybe I totally misunderstand the discussion, but why and whom would MNTA want to inform/impress by publishing such things?

What could they gain?

Thank you.